Ex-Medtronic CEO testifies in Gupta insider trading trial; Boston Heart Diagnostics launches new test;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Former Medtronic CEO William George, now a Goldman Sachs director, testified in Rajat Gupta's insider trading trial. Story

> Germany's INJEX Pharma has gained FDA clearance to market the company's needle-free injection device. Release

> Pennsylvania's Teleflex won 510(k) clearance for its new closed tip, multi-port epidural catheter. Release

> Boston Heart Diagnostics is launching a new Statin Induced Myopathy Genotype test designed to diagnose patients at risk of developing myopathy, as a side effect related to statin drugs. Release

> Austria's Miracor Medical Systems has nailed down a number of new U.S. patents for its PICSO (pressure-controlled intermittent coronary sinus occlusion) system to treat severe heart attack patients. Release

Pharma News

 @FiercePharma:  Endo's lobbying yields a provision in House user-fee bill that could protect its Lidoderm patch--NYTMore | Follow @FiercePharma

> Another FDA warning for J&J's McNeil unit. News

> Endo seeks protections in House FDA reauthorization. Item

> Stada must join the generics buyout binge, CEO says. Story

> How does Genentech like it under Roche's wing? Article

Biotech News

 @FierceBiotech: California's CIRM votes to shift stem cell grants toward clinical development side. More | Follow @FierceBiotech

 @JohnCFierce: In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test. (Not what they need right now.) Item | Follow @JohnCFierce

 @RyanMFierce: 23andMe's Google ties make today's news of the gene patent less surprising. News | Follow @RyanMFierce

> Trial vets at Flexion claim PhIIb success with lead osteoarthritis drug. Article

> China readies plan to spur its booming biotech sector. Story

> Bristol-Myers pushes latest blockbuster cancer drug prospect into ASCO spotlight. Report

> BMS creates global cancer drug collaboration. More

Drug Delivery News

 @DamianFierce: Perhaps you can have too much of a good thing. Penn researchers say too many nanocarriers render treatments ineffective: Story | Follow @DamianFierce

> MIT develops needle-free jet injector. More

> Delivery firm seeks $3M for transdermal platform. Story

> West Pharma looks to cash in on biosimilar delivery. Report

> IntelGenx eyes FDA nod with anti-migraine film results. Item

Biomarkers News

> Biomarkers help select the most fertile donors. News

> The economics and value of genetic biomarkers. Story

> Fitness as a biomarker in breast cancer. More

> Bile duct biomarker screening for fluke-linked cancer. Article

And Finally... Chembio Diagnostics is in the final stages of gearing up to start trading on the Nasdaq capital market. Release

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.